デフォルト表紙
市場調査レポート
商品コード
1620803

放射線腫瘍学市場:製品、技術、適応症、エンドユーザー別-2025-2030年の世界予測

Radiation Oncology Market by Product (Hardware, Services, Software), Technology (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Indication, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 191 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
放射線腫瘍学市場:製品、技術、適応症、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

放射線腫瘍学市場は、2023年に101億3,000万米ドルと評価され、2024年には108億5,000万米ドルに達すると予測され、CAGR 7.28%で成長し、2030年には165億7,000万米ドルになると予測されています。

放射線腫瘍学は腫瘍学の重要なサブスペシャリティであり、電離放射線を使用してがんを治療します。悪性腫瘍や一部の良性疾患の管理において重要な役割を担っており、健康な組織へのダメージを最小限に抑えるために精度を重視しています。世界のがん罹患率の増加により、強度変調放射線治療(IMRT)、定位放射線手術、陽子線治療など、治療の有効性と患者の転帰を高める高度な放射線技術の必要性が浮き彫りになっています。主な応用分野は、病院、がん治療センター、研究機関などです。高齢者人口の増加と先進治療に対する意識の高まりが市場成長の原動力となっています。より良い治療計画のためのAI統合や、コンパクトでコスト効率の高い陽子線治療装置の開発のような技術の進歩は、大きな機会をもたらします。企業は、AI主導の治療カスタマイズやヘルスケアインフラが未発達な新興市場に投資することで、こうした動向を活用することができます。しかし、同市場は、多額の設備投資を必要とする先進的な放射線治療装置の高コストや、熟練した専門家の不足といった課題に直面しており、資源が限られている地域での市場拡大の妨げになる可能性があります。さらに、機器承認のための厳しい規制要件が市場参入を遅らせる可能性もあります。こうした障壁があるにもかかわらず、ポータブル治療装置の技術革新や精密医療のためのAIアルゴリズムの改善は有望です。副作用の軽減と治療比率の向上に焦点を当てた調査は、治療をより身近で効率的なものにすることで事業の成長を促進することができます。市場競争は激しく、既存企業も新規参入企業も技術的進歩や戦略的提携に注力しています。最適な成長のためには、企業は共同研究、ヘルスケア専門家に対する継続的な教育プログラム、新興経済諸国のニーズに合わせた費用対効果の高いソリューションの開発を重視すべきです。こうした点に取り組むことで、企業は放射線腫瘍学市場特有の課題を克服しながら、成長機会を活用することができます。

主な市場の統計
基準年[2023] 101億3,000万米ドル
推定年[2024] 108億5,000万米ドル
予測年[2030] 165億7,000万米ドル
CAGR(%) 7.28%

市場力学:急速に進化する放射線腫瘍学市場の主要市場インサイトを公開

放射線腫瘍学市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • がんの蔓延と放射線治療の採用増加
    • 低侵襲治療への嗜好の高まり
    • がん治療に対する認識とアクセシビリティを広めるための政府の取り組み
  • 市場抑制要因
    • 放射線治療機器に関連する高コスト
  • 市場機会
    • 放射線治療機器の技術的進歩
    • 放射線腫瘍学治療の研究開発に対する継続的な非政府投資
  • 市場の課題
    • 訓練された放射線腫瘍学専門家の不足と厳しい規制遵守と承認

ポーターのファイブフォース:放射線腫瘍学市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、放射線腫瘍学市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:放射線腫瘍学市場における外部からの影響の把握

外部マクロ環境要因は、放射線腫瘍学市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析放射線腫瘍学市場における競合情勢の把握

放射線腫瘍学市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス放射線腫瘍学市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、放射線腫瘍学市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨放射線腫瘍学市場における成功への道筋を描く

放射線腫瘍学市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • がんの蔓延と放射線治療の導入の増加
      • 低侵襲手術への関心の高まり
      • がん治療への認知とアクセスを広めるための政府の取り組み
    • 抑制要因
      • 放射線治療機器に関連する高コスト
    • 機会
      • 放射線治療機器の技術的進歩
      • 放射線腫瘍学治療の研究開発への継続的な非政府投資
    • 課題
      • 訓練を受けた放射線腫瘍学専門家の不足と、厳格な規制遵守および承認
  • 市場セグメンテーション分析
    • 製品:放射線腫瘍学ハードウェアの大幅な普及
    • 技術:外部放射線療法を利用して健康な組織への被ばくを最小限に抑え、患者の転帰を改善する
    • 応用:乳がん治療における放射線腫瘍学の重視
    • エンドユーザー:総合的ながん治療を提供するための病院部門における放射線腫瘍学の潜在的な使用
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 放射線腫瘍学市場:製品別

  • ハードウェア
  • サービス
  • ソフトウェア

第7章 放射線腫瘍学市場:技術別

  • 外部放射線治療
    • コンパクトな先進放射線治療システム
      • サイバーナイフ
      • ガンマナイフ
      • トモセラピー
    • 線形加速器(リニアック)
    • 陽子線治療
      • サイクロトロン
      • シンクロトロン
  • 内部放射線治療
    • 近接放射線療法
      • アプリケーターとアフターローダー
      • 電子小線源治療
      • 種子
    • 全身放射線治療

第8章 放射線腫瘍学市場適応症別

  • 血液がん
  • 乳がん
  • 消化器がん
  • 前立腺がん
  • 呼吸器および肺がん
  • 皮膚がん

第9章 放射線腫瘍学市場:エンドユーザー別

  • 病院
  • 独立放射線治療センター

第10章 南北アメリカの放射線腫瘍学市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の放射線腫瘍学市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの放射線腫瘍学市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • アポロ・キャンサー・センターとアキュレイが提携し、インドのロボットおよび定位放射線手術教育センターを設立
    • エレクタ、ESTRO 2024で適応型・個別化がん治療のためのAI強化型CTリニアック「Evo」を発表
    • GEヘルスケア、 ESTROで先進的な放射線治療のイノベーションを発表2024
  • 戦略分析と提言

企業一覧

  • Accuray Incorporated
  • Becton, Dickinson and Company
  • Bionix LLC
  • BrainLab AG
  • Canon Inc.
  • Carl Zeiss AG
  • Eckert and Ziegler AG
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • IntraOp Medical, Inc.
  • Ion Beam Applications S.A.
  • Isoray Inc.
  • Koninklijke Philips N.V.
  • Nordion Inc.
  • Optivus Proton Therapy, Inc.
  • P-Cure LTD.
  • Panacea Medical Technologies Pvt. LTD.
  • Provision Healthcare, LLC
  • Siemens Healthineers AG
  • Stryker Corporation
  • Sumitomo Heavy Industries, LTD
  • Theragenics Corporation
  • ViewRay, Inc.
図表

LIST OF FIGURES

  • FIGURE 1. RADIATION ONCOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. RADIATION ONCOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. RADIATION ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RADIATION ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RADIATION ONCOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RADIATION ONCOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYBERKNIFE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TOMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LINEAR ACCELERATORS (LINAC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYCLOTRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SYNCHROTRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATORS & AFTER LOADERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY ELECTRONIC BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SYSTEMIC BEAM RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY & LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR RADIATION ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLI
目次
Product Code: MRR-035AB9C0DA6B

The Radiation Oncology Market was valued at USD 10.13 billion in 2023, expected to reach USD 10.85 billion in 2024, and is projected to grow at a CAGR of 7.28%, to USD 16.57 billion by 2030.

Radiation oncology, a critical subspecialty of oncology, involves using ionizing radiation to treat cancer. It plays a vital role in managing malignancies and some benign conditions, emphasizing precision to minimize damage to healthy tissue. The increasing prevalence of cancer globally underscores the necessity for advanced radiation techniques, such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery, and proton therapy, which enhance treatment efficacy and patient outcomes. Key application areas include hospitals, cancer treatment centers, and research institutes. The rising geriatric population and increasing awareness of advanced therapies drive market growth. Technological advancements, like AI integration for better treatment planning and the development of compact and cost-efficient proton therapy units, present significant opportunities. Companies can capitalize on these trends by investing in AI-driven treatment customization and emerging markets with underdeveloped healthcare infrastructure. However, the market faces challenges such as the high cost of advanced radiotherapy equipment, requiring substantial capital investment, and the shortage of skilled professionals, which may hinder market expansion in regions with limited resources. Moreover, stringent regulatory requirements for equipment approval can delay market entry. Despite these barriers, innovation in portable therapy units and improving AI algorithms for precision medicine is promising. Research focusing on reducing side effects and enhancing the therapeutic ratio can drive business growth by making treatments more accessible and efficient. The market is competitive, with established companies and new entrants focusing on technological advancements and strategic partnerships. For optimal growth, businesses should emphasize collaborative research, continuous education programs for healthcare professionals, and development of cost-effective solutions tailored to emerging economies' needs. Addressing these aspects can position companies to leverage growth opportunities while navigating the inherent challenges of the radiation oncology market.

KEY MARKET STATISTICS
Base Year [2023] USD 10.13 billion
Estimated Year [2024] USD 10.85 billion
Forecast Year [2030] USD 16.57 billion
CAGR (%) 7.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Radiation Oncology Market

The Radiation Oncology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cancer and increasing adoption of radiation procedures
    • Rising preference for minimally invasive procedures
    • Government initiatives to spread awareness and accessibility to cancer treatment
  • Market Restraints
    • High costs associated with radiotherapy equipment
  • Market Opportunities
    • Technological advancements in radiation therapy equipment
    • Ongoing non-government investments in R&D of radiation oncology treatment
  • Market Challenges
    • Shortage of trained radiation oncology professionals coupled with stringed regulatory compliances and approvals

Porter's Five Forces: A Strategic Tool for Navigating the Radiation Oncology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Radiation Oncology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Radiation Oncology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Radiation Oncology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Radiation Oncology Market

A detailed market share analysis in the Radiation Oncology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Radiation Oncology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Radiation Oncology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Radiation Oncology Market

A strategic analysis of the Radiation Oncology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Radiation Oncology Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Becton, Dickinson and Company, Bionix LLC, BrainLab AG, Canon Inc., Carl Zeiss AG, Eckert and Ziegler AG, Elekta AB, GE HealthCare Technologies Inc., Hitachi, Ltd., Hologic, Inc., IntraOp Medical, Inc., Ion Beam Applications S.A., Isoray Inc., Koninklijke Philips N.V., Nordion Inc., Optivus Proton Therapy, Inc., P-Cure LTD., Panacea Medical Technologies Pvt. LTD., Provision Healthcare, LLC, Siemens Healthineers AG, Stryker Corporation, Sumitomo Heavy Industries, LTD, Theragenics Corporation, and ViewRay, Inc..

Market Segmentation & Coverage

This research report categorizes the Radiation Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Hardware, Services, and Software.
  • Based on Technology, market is studied across External Beam Radiation Therapy and Internal Beam Radiation Therapy. The External Beam Radiation Therapy is further studied across Compact advanced radiotherapy systems, Linear Accelerators (Linac), and Proton Therapy. The Compact advanced radiotherapy systems is further studied across Cyberknife, Gamma Knife, and Tomotherapy. The Proton Therapy is further studied across Cyclotron and Synchrotron. The Internal Beam Radiation Therapy is further studied across Brachytherapy and Systemic Beam Radiation Therapy. The Brachytherapy is further studied across Applicators & After loaders, Electronic Brachytherapy, and Seeds.
  • Based on Indication, market is studied across Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory & Lung Cancer, and Skin Cancer.
  • Based on End-User, market is studied across Hospitals and Independent Radiotherapy Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cancer and increasing adoption of radiation procedures
      • 5.1.1.2. Rising preference for minimally invasive procedures
      • 5.1.1.3. Government initiatives to spread awareness and accessibility to cancer treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with radiotherapy equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in radiation therapy equipment
      • 5.1.3.2. Ongoing non-government investments in R&D of radiation oncology treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained radiation oncology professionals coupled with stringed regulatory compliances and approvals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant penetration of radiation oncology hardware
    • 5.2.2. Technology: Utilization of external beam radiation therapy to minimize exposure to healthy tissues and improve patient outcomes
    • 5.2.3. Application: Significant emphasis on radiation oncology for breast cancer treatment
    • 5.2.4. End-User: Potential use of radiation oncology in hospital sectors to provide comprehensive cancer care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Radiation Oncology Market, by Product

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Radiation Oncology Market, by Technology

  • 7.1. Introduction
  • 7.2. External Beam Radiation Therapy
    • 7.2.1. Compact advanced radiotherapy systems
      • 7.2.1.1. Cyberknife
      • 7.2.1.2. Gamma Knife
      • 7.2.1.3. Tomotherapy
    • 7.2.2. Linear Accelerators (Linac)
    • 7.2.3. Proton Therapy
      • 7.2.3.1. Cyclotron
      • 7.2.3.2. Synchrotron
  • 7.3. Internal Beam Radiation Therapy
    • 7.3.1. Brachytherapy
      • 7.3.1.1. Applicators & After loaders
      • 7.3.1.2. Electronic Brachytherapy
      • 7.3.1.3. Seeds
    • 7.3.2. Systemic Beam Radiation Therapy

8. Radiation Oncology Market, by Indication

  • 8.1. Introduction
  • 8.2. Blood Cancer
  • 8.3. Breast Cancer
  • 8.4. Gastrointestinal Cancer
  • 8.5. Prostate Cancer
  • 8.6. Respiratory & Lung Cancer
  • 8.7. Skin Cancer

9. Radiation Oncology Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Independent Radiotherapy Centers

10. Americas Radiation Oncology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Radiation Oncology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Radiation Oncology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Apollo Cancer Centres and Accuray Partner to Launch India's Robotic and Stereotactic Radiosurgery Education Center
    • 13.3.2. Elekta Unveils Evo at ESTRO 2024 New AI-Enhanced CT-Linac for Adaptive and Personalized Cancer Therapy
    • 13.3.3. GE HealthCare Unveils Advanced Radiation Therapy Innovations at ESTRO 2024
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Becton, Dickinson and Company
  • 3. Bionix LLC
  • 4. BrainLab AG
  • 5. Canon Inc.
  • 6. Carl Zeiss AG
  • 7. Eckert and Ziegler AG
  • 8. Elekta AB
  • 9. GE HealthCare Technologies Inc.
  • 10. Hitachi, Ltd.
  • 11. Hologic, Inc.
  • 12. IntraOp Medical, Inc.
  • 13. Ion Beam Applications S.A.
  • 14. Isoray Inc.
  • 15. Koninklijke Philips N.V.
  • 16. Nordion Inc.
  • 17. Optivus Proton Therapy, Inc.
  • 18. P-Cure LTD.
  • 19. Panacea Medical Technologies Pvt. LTD.
  • 20. Provision Healthcare, LLC
  • 21. Siemens Healthineers AG
  • 22. Stryker Corporation
  • 23. Sumitomo Heavy Industries, LTD
  • 24. Theragenics Corporation
  • 25. ViewRay, Inc.